MC3 Biolung artificial lung implant

                                                               -->next

The BioLung is an artificial lung that can replace the gas exchange function of a person’s native lungs during recovery from injury or illness, or until donor lungs are available for transplantation.

Concept → Design → Development → Pre-Production
MC3 engineers designed and patented the BioLung and designed and constructed the necessary fabrication equipment. Further development was completed through laboratory testing in conjunction with academic collaborators and with support from NIH. MC3 followed FDA-appropriate design control and documentation procedures, and transferred the BioLung to production. The BioLung is currently undergoing testing for FDA submission.

Commercialization
MC3 participated in the founding of Novalung, GmbH, a German company dedicated to providing devices to treat lung failure, including artificial lungs. MC3 plans to market the BioLung through Novalung.


Comments